Authorities have asked for help from the public in finding an endangered man with cognitive delays. Brian Piper, 56, of ...

Such is the case with newly approved Bristol-Myers Squibb drug Cobenfy. The underlying drug was first studied in Alzheimer’s ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

Doctors sometimes use lithium to treat schizophrenia. However, it is not a primary treatment method and evidence of its ...

A new study reveals a genetic connection between bipolar disorder type I (BD-I) and epilepsy, showing shared genetic variants ...

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely ...

The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

For the first time in nearly 30 years, the U.S. Food and Drug Administration has approved a new drug treating schizophrenia, ...

Millions of Americans are affected by psychosis, a condition that includes schizophrenia, bipolar disorder, and depression.

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...